Invited commentary.
Ankersmit
Hendrik Jan
HJ
Department of Cardiothoracic Surgery, General Hospital Vienna, Meduniwien, Währinger Gürtel 18-20, Vienna, A-1090 Austria.
Moser
Bernhard
B
Wolner
Ernst
E
D004198:Disease Susceptibility; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology; D006353:Heart-Assist Devices / Q000009:adverse effects; D006801:Humans; D007114:Immunization; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007239:Infections / Q000209:etiology; D011673:Pulsatile Flow; D012189:Retrospective Studies; D017211:Treatment Failure
D006680:HLA Antigens; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents